10-Q
Quarterly Report
Exousia Bio, Inc.
CIK: 1939937
File #: 000-56599
Balance Sheet
36 line items · 2 periods
XBRL
| Item | Feb 28, 2026 | May 31, 2025 |
|---|---|---|
ASSETS | ||
Current Assets | ||
Cash & cash equivalents | 0 | 0 |
Accounts Receivable | 0 | 0 |
Other Non-Operating Current Assets | 0 | 0 |
Total current assets | 0 | 0 |
Non-current assets | ||
Intangible Assets | 0 | 0 |
Property, Plant and Equipment | 670 | 0 |
Other Non-Operating Non-Current Assets | 22,050,000 | 0 |
Total Non-current Assets | 22,050,670 | 0 |
TOTAL ASSETS | 22,050,670 | 0 |
LIABILITIES AND STOCKHOLDERS’ EQUITY/(DEFICIT) | ||
Current Liabilities | ||
Due to related party | 8,831 | 0 |
Advances from related parties | 38,850 | 0 |
Accounts Payable | 212,302 | 0 |
Other Non-Operating Current Liabilities | 1,040 | 0 |
Total current liabilities | 261,023 | 0 |
Non-Current Liabilities | ||
Loans from related parties | 0 | 0 |
Note payable – related party | 0 | 0 |
Short-Term Debt | 0 | 0 |
Other Non-Operating Current Liabilities | 0 | 0 |
Total non-current liabilities | 0 | 0 |
Total Liabilities | 261,023 | 0 |
Stockholders’ Equity (Deficit) | ||
Total Stockholders' Equity | 7,350 | 778 |
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 22,070,920 | 30,992 |
Total Stockholders' Equity | (288,623) | (31,770) |
Total Stockholders’ equity (deficit) | 21,789,647 | 0 |
Common Stock | 7,350 | 778 |
Additional Paid-in Capital | 22,070,920 | 30,992 |
Retained Earnings | (288,623) | (31,770) |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | 22,050,670 | 0 |